845543-57-9

Basic information

• Product Name: Carbamic acid, [(1S)-2-(3,5-difluorophenyl)-1-(hydroxymethyl)ethyl]-, 1,1-dimethylethyl ester
• CAS NO: 845543-57-9
• Molecular Formula: C14H19F2NO3
• Molecular Weight: 287.307
• Mol File: 845543-57-9.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: Carbamic acid, [(1S)-2-(3,5-difluorophenyl)-1-(hydroxymethyl)ethyl]-, 1,1-dimethylethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Carbamic acid, [(1S)-2-(3,5-difluorophenyl)-1-(hydroxymethyl)ethyl]-, 1,1-dimethylethyl ester(845543-57-9)
• EPA Substance Registry System: Carbamic acid, [(1S)-2-(3,5-difluorophenyl)-1-(hydroxymethyl)ethyl]-, 1,1-dimethylethyl ester(845543-57-9)

Safety Data

• Hazardous Substances Data: 845543-57-9(Hazardous Substances Data)

Upstream product

• 13734-34-4 N-tert-butoxycarbonyl-L-phenylalanine 
• 205445-52-9 (2S)-2-[(tert-butoxycarbonyl)amino]-3-(3,5-difluorophenyl)propanoic acid 
• 362480-01-1 (S)-tert-butyl 3-(3,5-difluorophenyl)-1-(methoxy(methyl)amino)-1-oxopropan-2-ylcarbamate 

Downstream Products

• 869657-95-4 (2S)-3,5-difluorophenylalaninol 
• 362480-02-2 (S)-[1-(3,5-difluorobenzyl)-2-oxo-ethyl]-carbamic acid tert-butyl ester 
• 1430058-24-4 C₂₂H₂₂F₂N₂O₄ 
• 1047646-20-7 2-[(2S)-2-amino-3-(3,5-difluorophenyl)propyl]-1H-isoindole-1,3(2H)-dione hydrochloride 
• 1430058-26-6 2-[(2S)-2-(5-bromo-1-oxo-1,3-dihydro-2H-isoindol-2-yl)-3-(3,5-difluorophenyl)propyl]-1H-isoindole-1,3(2H)-dione 
• 1430058-28-8 2-[(2S)-2-[5-(1-methyl-1H-pyrazol-5-yl)-1-oxo-1,3-dihydro-2H-isoindol-2-yl]-3-(3,5-difluorophenyl)propyl]-1H-isoindole-1,3(2H)-dione 
• 1430056-80-6 2-[(1S)-2-amino-1-(3,5-difluorobenzyl)ethyl]-5-(1-methyl-1H-pyrazol-5-yl)isoindolin-1-one 
• 1430058-30-2 2-[(2S)-2-[5-(4-bromo-1-methyl-1H-pyrazol-5-yl)-1-oxo-1,3-dihydro-2H-isoindol-2-yl]-3-(3,5-difluorophenyl)propyl]-1H-isoindole-1,3(2H)-dione 
• 1430056-94-2 2-[(1S)-2-amino-1-(3,5-difluorobenzyl)ethyl]-5-(4-cyano-1-methyl-1H-pyrazol-5-yl)isoindolin-1-one 
• 1430058-32-4 C₃₀H₂₁F₂N₅O₃ 
• 845972-85-2 C₁₉H₂₂F₂N₂O₃ 
• 845972-83-0 C₁₉H₂₂F₂N₂O₃ 
• 845973-15-1 C₂₀H₂₄F₂N₂O₃ 
• 845973-43-5 C₃₃H₄₃F₂N₃O₆ 

Relevant articles and documents

ISOINDOLINONE AND PYRROLOPYRIDINONE DERIVATIVES AS AKT INHIBITORS

The present invention provides isoindolinone and pyrrolopyridinone derivatives, as well as their compositions and methods of use, that inhibit the activity of the serine/threonine kinase, Akt, and are useful in the treatment of diseases related to the act

METHODS OF TREATMENT OF AMYLOIDOSIS USING ETHANOLCYCLICAMINE ASPARTYL PROTEASE INHIBITORS

The invention relates to novel compounds and methods of treating diseases, disorders, and conditions associated with amyloidosis. Amyloidosis refers to a collection of diseases, disorders, and conditions associated with abnormal deposition of A-beta prote

CYCLIC AMINE BASE-1 INHIBITORS HAVING A HETEROCYCLIC SUBSTITUENT

Disclosed are novel compounds of the formula (I)or a pharmaceutically acceptable salt or solvate thereof, wherein R1 is formula (I) X is -0-, -C(R14)2- or -N(R)-; Z is -C(R14)2- or -N(R)-; t is 0, 1, 2 or 3; each R and R2 is independently H, alkyl, cycloalkyl, cycloalkylalkyl, aryl, heteroaryl, heterocycloalkyl, arylalkyl, heteroarylalkyl, heterocycloalkylalkyl, alkenyl or alkynyl; each R14 is H, alkyl, alkenyl, alkynyl, halo, -CN, haloalkyl, cycloalkyl, cycloalkylalkyl, aryl, heteroaryl, heterocycloalkyl, arylalkyl, heteroarylalkyl, heterocycloalkylalkyl, -OR35, -N(R24)(R25)or -SR35; R41 is alkyl, cycloalkyl, -S02(alkyl), -C(O)-alkyl, -C(O)-cycloalkyl or -alkyl-NH-C(O)CH3; and the remaining variables are as defined in the specification. Also disclosed are pharmaceutical compositions comprising the compounds of formula I and methods of treating cognitive or neurodegenerative diseases with compounds of formula (I). Also disclosed are pharmaceutical compositions and methods of treatment comprising compounds of formula I in combination with other agents useful in treating cognitive or neurodegenerative diseases.